U.S. market Closed. Opens in 34 minutes

CPRX | Catalyst Pharmaceuticals, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for CPRX we got that it has strong fundamentals where Valuation is considered to be undervalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is very strong.

Valuation (74%)

Company Industry
P/E Ratio (TTM) 18.01 -18.09
PEG Ratio (TTM) 0.16 -5.18
P/S Ratio (TTM) 5.60 52.20
P/B Ratio (TTM) 3.89 28.91
P/FCF Ratio (TTM) 13.72 -7.12
Price to 5YR AVG Earnings Ratio 37.39 -7.20
Price to 5YR AVG FCF Ratio 64.45 -13.31

Profitability (90%)

Company Industry
ROA (TTM) 18.50% -16.66%
ROE (TTM) 25.74% 27.93%
Net Profit Margin (TTM) 31.01% -796.50%
ROIC 5YR AVG 93.18% -20.53%

Growth (100%)

4QTR AVG 3YR AVG 5YR AVG
EPS 63.78% 92.99% 74.65%
Revenue 6.55% 6,798.64% 4,106.79%
Net Income 65.73% 93.88% 75.60%
Cash Flow 23.80% 99.61% 82.96%

Health (77%)

Company Industry
Current Ratio (TTM) 5.11 5.80
Quick Ratio (TTM) 4.92 5.58
D/E Ratio (TTM) 0.00 0.97
Interest Coverage (TTM) N/A -7.65
Piotroski F-Score 6 5
Altman Z-Score 16.42 13.09
LTL to 5YR AVG FCF 0.16 0.07
Shares Outstanding Growth 5YR AVG 0.71% 40.92%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙